Clinical Trial Update: Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML) [Phase 1]

View source ↗

Summary

A Phase I clinical trial in Chinese patients with acute myeloid leukemia evaluating cafusertib hydrochloride in combination with low-dose cytarabine. The curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Cafusertib hydrochloride (cafusertib hydrochloride)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Leukemia, Myeloid, Acute | Phase 1 | Status: UNKNOWN